03:13 AM EDT, 03/18/2025 (MT Newswires) -- Srinivas Akkaraju, Director, on March 13, 2025, executed a purchase for 600,000 shares in Mineralys Therapeutics ( MLYS ) for $8,100,000. Following the Form 4 filing with the SEC, Akkaraju has control over a total of 5,674,916 common shares of the company, with 5,674,916 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1933414/000141588925008274/xslF345X05/form4-03182025_010312.xml